Brand-name versus generic drugs

Health Affairs

Volumn 30, Issue 10, 2011, Pages 2027-2028

  Manning, Richard ^a   Smith, Richard ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Pharmaceutical Research and Manufacturers of America   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; PRESCRIPTION DRUG;

DRUG COST; DRUG MARKETING; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; LETTER; PRESCRIPTION; PRODUCT DEVELOPMENT;

CHRONIC DISEASE; COST SAVINGS; DRUG COSTS; DRUGS, GENERIC; FEMALE; HEALTH CARE REFORM; HUMANS; MALE;

EID: 84862941745     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0964     Document Type: Letter

References (0)